Stanley Druckenmiller: portfolio of Duquesne Family Office

Stanley Druckenmiller manages his own wealth through the Duquesne Family Office; earlier he ran the macro fund Duquesne Capital.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 15, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2025. Go to the latest filing (Q3 2026)

3.9B USDQ2 2025
Total value of stock positions
3.9B USD
Positions
65
Share of the ten largest
52.6%

The ten largest positions Q2 2025

  1. Natera Inc 13.3%▼ −9.3%
  2. Teva Pharmaceutical Inds Ltd 6.8%▲ +7.3%
  3. Insmed Inc 5.8%▲ +64.6%
  4. Woodward Inc 5.3%▼ −22.7%
  5. Taiwan Semiconductor Manufacturing (ADR) 4.4%▲ +27.8%
  6. Philip Morris International 3.8%▼ −26.2%
  7. MercadoLibre 3.6%unchanged
  8. Entegris Inc 3.4%new
  9. Coupang Inc 3.1%▼ −55.9%
  10. Flutter Entmt Plc 3.0%▲ +7.4%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 4.5B USD).
Choose a quarter (54 filings)

All positions Q2 2025

Positions Q2 2025 per 13F filing, 15 of 15
Symbol Weight in previous quarter Shares in previous quarter Value in previous quarter Change
COF Capital One 1.2% 197,670 35.4M USD sold out
Springworks Therapeutics Inc 0.9% 615,929 27.2M USD sold out
AMZN Amazon 0.9% 136,765 26.0M USD sold out
Ascendis Pharma A/S 0.8% 158,720 24.7M USD sold out
Brookfield Corp 0.6% 315,925 16.6M USD sold out
Teck Resources Ltd 0.5% 431,545 15.7M USD sold out
Bridgebio Pharma Inc 0.5% 438,050 15.1M USD sold out
FLEX Flex Ltd. 0.4% 348,900 11.5M USD sold out
EXE Expand Energy 0.4% 97,700 10.9M USD sold out
Antero Resources Corp 0.4% 258,400 10.5M USD sold out
Impinj Inc 0.3% 108,475 9.8M USD sold out
TSLA Tesla, Inc. 0.2% 18,838 4.9M USD sold out
Ultragenyx Pharmaceutical In 0.1% 85,445 3.1M USD sold out
American Airl < 0.1% 133,728 1.4M USD sold out
Invivyd Inc < 0.1% 571,425 346.0K USD sold out
Plus 4 option positions, value of the underlying shares as reported 157.3M USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • Ishares Tr Call 72.3M USD
  • Spdr S&P 500 Etf Tr Call 55.6M USD
  • Natera Inc Call 19.3M USD
  • Insmed Inc Call 10.1M USD

Breakdown by sector

  • Technology 11.7%
  • Consumer Staples 3.8%
  • Health Care 3.0%
  • Industrials 2.7%
  • Energy 2.7%
  • Financials 2.6%
  • Consumer Discretionary 1.0%
  • Communication Services 0.8%
  • Materials 0.2%
  • not in our coverage 71.4%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close